Clinical Trial Update: Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ertugliflozin to hydrochlorothiazide for reducing sympathetic neural overactivity in patients with hypertension and recently diagnosed t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Ertugliflozin (ertugliflozin)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Hypertension, Diabetes Mellitus, Type 2 | Phase 4 | Status: WITHDRAWN